Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: BAD

Gene summary for BAD

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

BAD

Gene ID

572

Gene nameBCL2 associated agonist of cell death
Gene AliasBBC2
Cytomap11q13.1
Gene Typeprotein-coding
GO ID

GO:0000003

UniProtAcc

A0A024R562


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
572BADAEH-subject1HumanEndometriumAEH1.11e-12-2.60e-01-0.3059
572BADAEH-subject2HumanEndometriumAEH1.95e-06-2.58e-01-0.2525
572BADAEH-subject3HumanEndometriumAEH4.47e-07-1.68e-01-0.2576
572BADAEH-subject4HumanEndometriumAEH1.47e-06-2.53e-01-0.2657
572BADAEH-subject5HumanEndometriumAEH7.79e-14-3.91e-01-0.2953
572BADEEC-subject1HumanEndometriumEEC9.41e-18-3.33e-01-0.2682
572BADEEC-subject2HumanEndometriumEEC2.85e-06-2.21e-01-0.2607
572BADEEC-subject3HumanEndometriumEEC3.83e-39-4.12e-01-0.2525
572BADEEC-subject4HumanEndometriumEEC1.48e-06-2.43e-01-0.2571
572BADEEC-subject5HumanEndometriumEEC1.26e-03-2.44e-01-0.249
572BADGSM5276934HumanEndometriumEEC1.54e-17-3.89e-01-0.0913
572BADGSM5276937HumanEndometriumEEC1.66e-10-3.71e-01-0.0897
572BADGSM6177620_NYU_UCEC1_lib1_lib1HumanEndometriumEEC1.48e-25-4.68e-01-0.1869
572BADGSM6177620_NYU_UCEC1_lib2_lib2HumanEndometriumEEC1.12e-26-4.48e-01-0.1875
572BADGSM6177620_NYU_UCEC1_lib3_lib3HumanEndometriumEEC3.24e-30-4.48e-01-0.1883
572BADGSM6177621_NYU_UCEC2_lib1_lib1HumanEndometriumEEC3.56e-32-4.31e-01-0.1934
572BADGSM6177622_NYU_UCEC3_lib1_lib1HumanEndometriumEEC8.26e-43-4.73e-01-0.1917
572BADGSM6177622_NYU_UCEC3_lib2_lib2HumanEndometriumEEC3.92e-31-4.54e-01-0.1916
572BADGSM6177623_NYU_UCEC3_VisHumanEndometriumEEC5.00e-08-1.52e-01-0.1269
572BADLZE4THumanEsophagusESCC1.76e-216.87e-010.0811
Page: 1 2 3 4 5 6 7 8 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
EndometriumThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AEH: Atypical endometrial hyperplasia
EEC: Endometrioid Cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
ProstateThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.BPH: Benign Prostatic Hyperplasia
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:007048217ProstateBPHresponse to oxygen levels104/3107347/187233.13e-101.67e-08104
GO:20012359ProstateBPHpositive regulation of apoptotic signaling pathway50/3107126/187235.08e-102.56e-0850
GO:004328118ProstateBPHregulation of cysteine-type endopeptidase activity involved in apoptotic process71/3107209/187235.88e-102.89e-0871
GO:005254818ProstateBPHregulation of endopeptidase activity122/3107432/187236.10e-102.91e-08122
GO:005122217ProstateBPHpositive regulation of protein transport93/3107303/187236.94e-103.25e-0893
GO:190165417ProstateBPHresponse to ketone67/3107194/187238.10e-103.74e-0867
GO:000915018ProstateBPHpurine ribonucleotide metabolic process107/3107368/187231.18e-095.19e-08107
GO:200011618ProstateBPHregulation of cysteine-type endopeptidase activity76/3107235/187231.90e-097.79e-0876
GO:003629317ProstateBPHresponse to decreased oxygen levels96/3107322/187232.03e-098.26e-0896
GO:000166617ProstateBPHresponse to hypoxia92/3107307/187233.29e-091.27e-0792
GO:001095218ProstateBPHpositive regulation of peptidase activity66/3107197/187234.44e-091.66e-0766
GO:004578518ProstateBPHpositive regulation of cell adhesion120/3107437/187235.22e-091.90e-07120
GO:000683916ProstateBPHmitochondrial transport79/3107254/187236.77e-092.38e-0779
GO:000925917ProstateBPHribonucleotide metabolic process108/3107385/187238.73e-092.97e-07108
GO:000616318ProstateBPHpurine nucleotide metabolic process109/3107396/187232.28e-086.94e-07109
GO:001969317ProstateBPHribose phosphate metabolic process109/3107396/187232.28e-086.94e-07109
GO:001003818ProstateBPHresponse to metal ion104/3107373/187232.32e-086.99e-07104
GO:007252118ProstateBPHpurine-containing compound metabolic process113/3107416/187232.77e-088.13e-07113
GO:00107208ProstateBPHpositive regulation of cell development86/3107298/187237.11e-081.85e-0686
GO:00506739ProstateBPHepithelial cell proliferation116/3107437/187237.12e-081.85e-06116
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa0502020EndometriumAEHPrion disease110/1197273/84652.39e-272.44e-251.78e-25110
hsa0520826EndometriumAEHChemical carcinogenesis - reactive oxygen species91/1197223/84653.28e-231.33e-219.76e-2291
hsa0501420EndometriumAEHAmyotrophic lateral sclerosis123/1197364/84652.17e-227.82e-215.72e-21123
hsa0501020EndometriumAEHAlzheimer disease124/1197384/84651.20e-203.91e-192.86e-19124
hsa0502220EndometriumAEHPathways of neurodegeneration - multiple diseases137/1197476/84659.27e-182.32e-161.70e-16137
hsa0451015EndometriumAEHFocal adhesion58/1197203/84654.99e-087.37e-075.39e-0758
hsa0472216EndometriumAEHNeurotrophin signaling pathway31/1197119/84654.07e-043.07e-032.25e-0331
hsa0491920EndometriumAEHThyroid hormone signaling pathway30/1197121/84651.20e-037.52e-035.50e-0330
hsa0541726EndometriumAEHLipid and atherosclerosis47/1197215/84651.24e-037.62e-035.58e-0347
hsa052158EndometriumAEHProstate cancer25/119797/84651.68e-031.01e-027.39e-0325
hsa0421010EndometriumAEHApoptosis30/1197136/84657.72e-034.05e-022.96e-0230
hsa0517018EndometriumAEHHuman immunodeficiency virus 1 infection43/1197212/84658.19e-034.22e-023.09e-0243
hsa05020110EndometriumAEHPrion disease110/1197273/84652.39e-272.44e-251.78e-25110
hsa05208112EndometriumAEHChemical carcinogenesis - reactive oxygen species91/1197223/84653.28e-231.33e-219.76e-2291
hsa05014110EndometriumAEHAmyotrophic lateral sclerosis123/1197364/84652.17e-227.82e-215.72e-21123
hsa05010110EndometriumAEHAlzheimer disease124/1197384/84651.20e-203.91e-192.86e-19124
hsa05022110EndometriumAEHPathways of neurodegeneration - multiple diseases137/1197476/84659.27e-182.32e-161.70e-16137
hsa0451016EndometriumAEHFocal adhesion58/1197203/84654.99e-087.37e-075.39e-0758
hsa0472217EndometriumAEHNeurotrophin signaling pathway31/1197119/84654.07e-043.07e-032.25e-0331
hsa04919110EndometriumAEHThyroid hormone signaling pathway30/1197121/84651.20e-037.52e-035.50e-0330
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
BADMYOFIBEsophagusADJFIBCD1,SLC22A23,S100A3, etc.0.00e+00The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
BADINCAFEsophagusADJFIBCD1,SLC22A23,S100A3, etc.0.00e+00The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
BADSMCEsophagusESCCFIBCD1,SLC22A23,S100A3, etc.5.49e-03The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
BADFIBEsophagusESCCFIBCD1,SLC22A23,S100A3, etc.0.00e+00The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
BADSNVMissense_Mutationc.351G>Ap.Met117Ilep.M117IQ92934protein_codingdeleterious(0)probably_damaging(0.966)TCGA-AC-A23H-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownPD
BADSNVMissense_Mutationc.293N>Ap.Arg98Hisp.R98HQ92934protein_codingdeleterious(0.03)possibly_damaging(0.688)TCGA-EK-A2RK-01Cervixcervical & endocervical cancerFemale>=65I/IIUnknownUnknownSD
BADSNVMissense_Mutationc.57G>Cp.Glu19Aspp.E19DQ92934protein_codingtolerated_low_confidence(1)benign(0.001)TCGA-4N-A93T-01Colorectumcolon adenocarcinomaMale>=65III/IVChemotherapyxelodaSD
BADSNVMissense_Mutationrs775688969c.74N>Ap.Ser25Asnp.S25NQ92934protein_codingtolerated(0.13)benign(0.409)TCGA-AA-A010-01Colorectumcolon adenocarcinomaFemale<65I/IIChemotherapyfolinicCR
BADSNVMissense_Mutationnovelc.212G>Tp.Ser71Ilep.S71IQ92934protein_codingdeleterious(0.01)possibly_damaging(0.857)TCGA-AJ-A5DW-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
BADSNVMissense_Mutationnovelc.401N>Tp.Ser134Ilep.S134IQ92934protein_codingdeleterious(0)probably_damaging(0.998)TCGA-AX-A1CE-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnspecificPaclitaxelSD
BADSNVMissense_Mutationnovelc.485N>Ap.Gly162Glup.G162EQ92934protein_codingdeleterious_low_confidence(0)probably_damaging(1)TCGA-AX-A2HC-01Endometriumuterine corpus endometrioid carcinomaFemale<65III/IVChemotherapypaclitaxelPD
BADSNVMissense_Mutationc.298N>Ap.Ala100Thrp.A100TQ92934protein_codingdeleterious(0)probably_damaging(0.999)TCGA-D1-A17R-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
BADSNVMissense_Mutationc.128G>Ap.Gly43Aspp.G43DQ92934protein_codingtolerated(0.08)probably_damaging(1)TCGA-FI-A2D5-01Endometriumuterine corpus endometrioid carcinomaFemale<65III/IVChemotherapycarboplatinumPD
BADSNVMissense_Mutationc.483N>Tp.Arg161Serp.R161SQ92934protein_codingdeleterious_low_confidence(0)benign(0.272)TCGA-CH-5739-01Prostateprostate adenocarcinomaMale>=657UnknownUnknownSD
Page: 1 2 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
572BADKINASE, DRUGGABLE GENOMERUBOXISTAURINRUBOXISTAURIN18077363
572BADKINASE, DRUGGABLE GENOMEAT-101ISOSORBIDE
Page: 1